APA

Vivekanandan S., Breene R., Ramanujachar R., Traunecker H., Pizer B., Gaze M. N., Saran F., Thorp N., English M., Wheeler K., Michalski A., Walker D. A., Saunders D., Cowie F., Cameron A., Picton S., Parashar D., Horan G. & Williams M. V. (20160816). Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). : Pediatric blood & cancer.

Chicago

Vivekanandan Sindu, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze M N, Saran F, Thorp N, English M, Wheeler K, Michalski A, Walker D A, Saunders D, Cowie F, Cameron A, Picton S, Parashar D, Horan G and Williams M V. 20160816. Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). : Pediatric blood & cancer.

Harvard

Vivekanandan S., Breene R., Ramanujachar R., Traunecker H., Pizer B., Gaze M. N., Saran F., Thorp N., English M., Wheeler K., Michalski A., Walker D. A., Saunders D., Cowie F., Cameron A., Picton S., Parashar D., Horan G. and Williams M. V. (20160816). Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). : Pediatric blood & cancer.

MLA

Vivekanandan Sindu, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze M N, Saran F, Thorp N, English M, Wheeler K, Michalski A, Walker D A, Saunders D, Cowie F, Cameron A, Picton S, Parashar D, Horan G and Williams M V. Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). : Pediatric blood & cancer. 20160816.